David C. Griffith,Michael N. Dudley,Mark W. Surber,Keith A. Bostian,Olga Rodny
申请号：
US15132122
公开号：
US20160287606A1
申请日:
2016.04.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.
